ULCOAT contains Sucralfate, which belongs to the group of medicines called Antiulcer agents. It is used in short-term management (up to 8 weeks) of active duodenal ulcers and maintenance therapy for duodenal ulcer (part of the small intestine) patients at reduced dosage after healing of acute ulcers.
Before taking ULCOAT inform your doctor if you have chronic renal disease, dialysis patients, and impaired swallowing/gag reflex (such as recent or prolonged intubation, tracheostomy, prior history of aspiration, dysphagia, or any other conditions that may alter gag and cough reflexes or diminish oropharyngeal coordination or motility).
ULCOAT should be used with caution among pregnant and breastfeeding women. Consult your doctor before taking it. The safety and effectiveness of ULCOAT for use in children have not been established. ULCOAT should be used with caution in elderly patients above 65 years of age. The most common side effect of taking ULCOAT is constipation. Consult your doctor if any of your symptoms get worse or persist.
No content available
